You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Brazil

Feb 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Brazil for free:

The Consumer Health in Brazil market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Brazil?
  • What are the major brands in Brazil?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health shows double-digit growth in 2010

Consumer health continued to show robust growth in 2010 driven by positive socioeconomic indicators such as growing disposable income and low unemployment rates. Low-income brackets that had limited access to medicines due to low purchasing power benefited the most. As a result, pharmaceutical manufacturers such as Sanofi-Aventis, Novartis and EMS announced investments to increase the production capacity through the opening of new facilities or acquisition of new machines.

Approval of tracking system for medicines

The pharmaceutical market suffers high losses every year with theft of medicines and informality. As a result, ANVISA (Health Surveillance Agency) approved RDC 59/09, which regulates the adoption of a tracking system of medicines in the production, imports, distribution, transportation and parapharmacies/drugstores through electronic seals that will be in every medicine, in order to reduce the incidence of theft of medicines, informality and tax evasion. The tracking system is expected to be entirely introduced over a 3-year period. The tracking system device has already been installed in more than 60,000 parapharmacies/drugstores.

Further acquisitions

The market continued to see further consolidation of companies in 2010. Hypermarcas which acquired Neo Química in December 2009 made another acquisition in March 2010, Luper Indústria Farmacêutica, to strengthen its consumer health portfolio and similar prescription medicines. Pfizer acquired 40% of Laboratório Teuto, the bulk of sales of which are concentrated in generic drugs, in October 2010. There are rumours of further acquisitions in the near future that include Mantecorp, responsible for the production and distribution of Polaramine (antihistamine remedy), and other national players like Cristália and Biolab.

Direct selling and internet retailing slowly increase sales

Parapharmacies/drugstores remains the most important channel for consumer health. However, direct selling and internet retailing both enjoyed significant growth over the review period driven by sales of vitamins and dietary supplements, weight management and sports nutrition since ANVISA (Health Surveillance Agency) no longer restricts sales to parapharmacies/drugstores. These two channels proved to be very convenient to consumers and more informative. In the case of direct selling, it is very common for salespeople to demonstrate all the benefits and advantage of the products.

Positive outlook for consumer health

With the election of Dilma Rouseff as President of Brazil over the 2011-215 period, it is expected that the fiscal and monetary policy will remain the same as it was under President Luís Inácio “Lula” da Silva. As a result, industries and consumers alike are optimistic that disposable income will continue to increase and unemployment rates will remain low. Therefore, consumer health is expected to show a great performance over the forecast period, driven mainly by greater access to medicines by socio-economic strata D and E.

Table of Contents

Table of Contents

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

Consumer health shows double-digit growth in 2010

Approval of tracking system for medicines

Further acquisitions

Direct selling and internet retailing slowly increase sales

Positive outlook for consumer health

KEY TRENDS AND DEVELOPMENTS

Further acquisitions in pharmaceutical market

Growing disposable income stimulates consumer health

Low presence of generics in OTC

Investment in the tracking system of medicines

Advances in herbal/traditional products regulation

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

De-reimbursement

Generics

Advertising

Packaging and Labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 Consumer Health Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Brazil - Company Profiles

Aché Laboratórios Farmacêuticos SA - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2010

Bayer (Brasil) SA - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Bayer SA: Competitive Position 2010

Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2010

Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios Ltda - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2010

EMS SA - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 EMS SA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 20 EMS SA: Competitive Position 2010

Eurofarma Laboratório Ltda - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2010

Hypermarcas SA - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 27 Hypermarcas SA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 28 Hypermarcas SA: Competitive Position 2010

Medley SA Indústria Farmacêutica - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 31 Medley SA Indústria Farmacêutica: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 32 Medley SA Indústria Farmacêutica: Competitive Position 2010

Nycomed Pharma Ltda - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 35 Nycomed Pharma Ltda: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 36 Nycomed Pharma Ltda: Competitive Position 2010

Sanofi-Aventis Farmacêutica Ltda - Consumer Health - Brazil

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 39 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2010

Adult Mouth Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • OTC adult mouth care continues to endure stiff competition from prescription products such as Gingilone and Omcilon-A Orabase and traditional recipes like sodium bicarbonate and rinsing the mouth with water, vinegar and sugar. As a result, there was little investment in adult mouth care. In fact, Colgate-Palmolive discontinued sales of Peroxyl and Hypermarcas withdrew Anapyon in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Colgate-Palmolive Indústria e Comércio is the leading company with a value share of more than 18% in 2010. However, the company saw its market share decline significantly as it discontinued sales of Peroxyl in early-2010. Hypermarcas also discontinued Anapyon, which is a traditional brand within adult mouth care.

PROSPECTS

  • Since it is not expected that products such as Gingilone and Omcilon-A Orabase, which has significant sales in prescription adult mouth care, will be switched in the short term, adult mouth care is estimated to decline by 9% in constant value terms over the forecast period. The lack of investment and competition with prescription drugs, which can be purchased without medical prescription, are the key issues that will hinder category growth.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Brazil - Category Analysis

HEADLINES

TRENDS

  • 2009 was marked by swine flu, which contributed to maintaining strong sales in that year. In 2010, analgesics continued to show robust growth driven by rising disposable income, especially amongst lower-income consumers, who had limited access to medicines in Brazil. According to Euromonitor International estimates, households with monthly disposable income over US$750 increased from 31.1% in 2005 to 46.8% in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis Farmacêutica remains the leading manufacturer within analgesics, holding a 23% value share in 2010, as a result of the strength of three brands in combination products, aspirin and dipyrone – Dorflex, AAS and Novalgina. Despite Dorflex continuing to increase its market share, AAS and Novalgina experienced declining share due to the competition within generics. Therefore, Sanofi-Aventis saw its share fall in 2010.

PROSPECTS

  • Branded analgesics will continue to face stiff competition from generics over the forecast period. As a result, it is expected that manufacturers will continue to invest in advertising campaigns and merchandising actions at the point-of-sale to promote their brands. There are some companies like Sanofi-Aventis which recently acquired Medley SA Indústria Farmacêutica, specialist in generics, and Hypermarcas which acquired Neo Química in early-2010, with a wide portfolio in generics, in a bid to maintain good performance in analgesics in the long term period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Brazil - Category Analysis

HEADLINES

TRENDS

  • Although demand for calming and sleeping products remains high, the performance of the category continued to be hindered due to the easy access consumers have to Rx calming and sleeping products such as products based on Valeriana officialis L. Physicians have also been prescribing this type of calming and sleeping product instead of the traditional Passiflora incarnata L, which is classified as OTC.

SWITCHES

COMPETITIVE LANDSCAPE

  • Marjan Indústria e Comércio Ltda and Produtos Farmacêuticos Millet Roux Ltda have a combined value share of more than 50% in 2010. Both companies continued to see increasing market share due to investment in promoting products among physicians.

PROSPECTS

  • Calming and sleeping products is estimated to grow at a CAGR of 4% in constant value terms over the forecast period. Slower growth is expected over the forecast period due to the fact that people are more interested in stronger calming and sleeping products (Rx medicines) due to high levels of stress and problems with insomnia.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil - Category Analysis

HEADLINES

TRENDS

  • After 2009 that was marked by swine flu, cough, cold and allergy remedies maintained the same pace of growth in 2010. The category grew by 11% in current value terms, registering more than R$3.4 billion. Low unemployment rates and rising disposable income, in particular among lower-income families, contributed to a greater proportion of the Brazilian population gaining access to medicines.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cadbury Adams Brasil Indústria e Comércio ranks first with a 12% value share in 2010, driven mainly by sales of Halls. The product has a wide distribution and it is available in supermarkets, hypermarkets, convenience stores, bakeries and parapharmacies/drugstores. However, the company has been losing share since 2003 as the performance of medicated confectionary remains below the overall category.

PROSPECTS

  • Cough, cold and allergy remedies is expected to maintain strong growth over the forecast period driven by the positive socio and economic indicators such as unemployment rates, disposable incomes and inflationary rates. Euromonitor International estimates that the category will grow at a CAGR of 5% in constant value terms from 2010 to 2015.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Brazil - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies continued to show robust growth in 2010, increasing by 12% in current value terms. According to trade specialists, the category benefited from the growing disposable income amongst lower-income brackets, which enabled further access to medicines. The northeast region is regarded as a key market by the industry to invest in as the population in that area is deprived of health assistance and households with a monthly disposable income of over US$500 have increased during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Brasil Ltda ranks first with a 15% value share in 2010. The company experienced share growth due to the great performance of Sal de Fruta Eno in antacids. The product has a long tradition in the market and it is available in three different flavours, guarana, lemon and orange, besides the original flavour.

PROSPECTS

  • Digestive remedies is predicted to increase at a CAGR of 5% in constant value terms from 2010 to 2015. The category will continue to benefit from growing disposable income among low-income consumers, especially from socio-economic strata C and D.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • In Brazil, there are only a few ear care products that are classified as OTC. Cerumin and Oto-Xilodase are among the products that are classified as non-prescription medicines and they are mainly positioned to help in removing wax from the ears and treat infections, in that order. It is very common, however, that people prefer to visit a doctor before self-medicating when it refers to ear problems since it is regarded as very sensitive.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratórios do Brasil leads ear care with Cerumin, responsible for more than 51% of value sales in 2010. The product has a long tradition in the market and thus it is well-known by consumers to help remove wax from ears. Since it is popular among Brazilian consumers, Alcon makes little investment in promoting the product.

PROSPECTS

  • With no expectation that ANVISA (Health Surveillance Agency) will switch to OTC status other principal ingredients during the forecast period, ear care is predicted to increase by 5% in constant value terms between 2010 and 2015, reaching over R$3 million by 2015.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • Eye care is predominantly driven by sales of standard eye care since allergy eye care is classified as a prescription medicine in Brazil. Despite standard eye care being classified as OTC, it is not frequently advertised by manufacturers as the Brazilian Society of Ophtamology and physicians encourage patients to seek specialist advice before self-medicating as the symptoms of dry eye, conjutivitis and allergies are similar.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratórios do Brasil is the outright leader in eye care, accounting for a value share of more than 44% in 2010. The company has a wide portfolio of products for red eyes and dry eyes that includes brands with different price points. For instance, Lácrima is a dry eye product that is available for R$12, while Oftane that is also a dry eye product is available for more than R$20 in parapharmacies/drugstores.

PROSPECTS

  • Eye care is predicted to increase by nearly 29% in constant value terms from 2010 to 2015, driven mainly by sales of dry eye products such as Lácrima, Fresh Tears, Claroft and other brands from Alcon and Allergan-Lok.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2005-2010
  • Table 53 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 54 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 55 Eye Care Company Shares by Value 2006-2010
  • Table 56 Eye Care Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Brazil - Category Analysis

HEADLINES

TRENDS

  • The National Policy on Medicinal Plants and Phytotherapy (Política Nacional de Plantas Medicinais e Fitoterápicos) established by the Brazilian government in 2006, which aims to promote and develop phytotherapy in the country, showed some advances in terms of guaranteeing the quality of phytotherapy products that are produced in the country by introducing new requirements in the registration process. Additionally, new rules for the “bulas” (information provided about the product inside packaging) were established, and RDC nº 10/2010 was introduced in early 2010, which provides information about the correct use of herbal/traditional products such as guaco, garlic, seeds of artichoke, etc. in a bid to avoid discrepancies in the information published by different manufacturers. Although these new rules show an advance in the phytotherapy market, it still did not have an impact on the performance of herbal/traditional products.

COMPETITIVE LANDSCAPE

  • Laboratório Canonne Ltda leads herbal/traditional products with a 19% value share in 2010, driven by sales of Valda (medicated confectionery) in herbal/traditional cough, cold and allergy remedies. The company, however, lost market share during the review period due to the weak performance of medicated confectionery compared to the overall category and stiff competition from pharyngeal preparations.

PROSPECTS

  • It is expected that further advances with The National Policy on Medicinal Plants and Phytotherapy (Política Nacional de Plantas Medicinais e Fitoterápicos) in the near future that will support sales of herbal/traditional products. New resolutions might be enacted during the forecast period regarding the registration of phytotherapy products and new plants that can be used to develop new medicines.

CATEGORY DATA

  • Table 59 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 60 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 61 Herbal/Traditional Products Company Shares 2006-2010
  • Table 62 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 63 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 64 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • Since Brazilians are very preoccupied with their appearance and it is very common for them to visit a dermatologist even to treat minor conditions, manufacturers saw the opportunity to increase investment in promoting their products to dermatologists and improve the visibility of the portfolio in parapharmacies/drugstores. Galderma Brasil Ltda and Laboratório Stiefel Ltda are among the companies that have made strong investments in this strategy. Other players such as Vichy and La Roche Posay were able to penetrate the Brazilian market through this strategy combined with premium positioning of their products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Procter & Gamble do Brasil SA continued to be leading player within medicated skin care, holding a 12% value share in 2010. After a declining market share during the review period due to the weak performance of Hipoglós, the company showed a slight increase in share as a result of investment in advertising campaigns to promote Hipoglós and the 70th anniversary of the brand in Brazil. This investment aimed to restore the tradition of the brand in nappy rash treatments.

PROSPECTS

  • Despite the great performance of medicated skin care over the review period, key players are expected to continue expanding their portfolios in cosmetics and toiletries more so than other medicated skin care categories as they can work with higher margins (CMED does not control prices as it does for medicines) and demand is estimated to remain strong over the forecast period. Laboratório Stiefel has increased investment in sun care and GlaxoSmithKline focused on emollients/therapeutic moisturisers.

CATEGORY DATA

  • Table 65 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 66 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 67 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 70 Acne Treatments Brand Shares by Value 2007-2010
  • Table 71 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Brazil - Category Analysis

HEADLINES

TRENDS

  • The smoking ban that was first instituted in the state of São Paulo in 2009 and adopted by other states the same year had a positive impact on sales of NRT smoking cessation aids. In 2010, the number of people who want to reduce or quit smoking continued to increase as the smoking ban also includes company premises and this becomes an issue when hiring or maintaining an employee since smokers tend to spend up to half an hour per day in smoking areas. Despite the smoking ban, the percentage of smokers remained steady from 2009 to 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Industrial is the outright leader in NRT smoking cessation aids with a 67% value share in 2010. The company increased its share due to investment in modern packaging and advertising campaigns on television and in magazines. The company also succeeded in entering NRT patches to compete against GlaxoSmithKline in 2009 and it currently holds more than a 20% value share in NRT patches.

PROSPECTS

  • The smoking ban that was adopted by many Brazilian states was positively supported by the population and smokers have respected the rules in public and private premises. This showed that the Brazilian population are increasingly aware of the danger and risks provoked by tobacco. Therefore, it is expected that the number of smokers trying to cut down or quit will continue to increase over the forecast period.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Brazil - Category Analysis

HEADLINES

TRENDS

  • Creatine was released by ANVISA (Health Surveillance Agency) to be sold as sport nutrition in May 2010. Prior to that, creatine was classified a medicine by ANVISA and sports nutrition manufacturers had to follow the proper obligation of any pharmaceutical company to produce and distribute creatine in Brazil. When ANVISA switched the status of creatine to medicine, no company was able to release creatine as medicine as there were no definitive rules established by the Brazilian health agency.

COMPETITIVE LANDSCAPE

  • Probiótica Laboratórios Ltda is the leading manufacturer of sports nutrition, accounting for 31% of value sales in 2010. The company has a wide portfolio in sports nutrition which includes whey protein, amino acids, carbohydrates, packs, mass gainers and creatine. The company is acknowledged to have high quality products as it also exports to foreign countries like the US and some countries in Europe.

PROSPECTS

  • Sports nutrition is expected to show a strong performance over the forecast period. Euromonitor International estimates that sports nutrition will increase at a CAGR of 16% in constant value terms as a result of the release of creatine and caffeine, which can be mixed with other supplements like whey protein and amino acids.

CATEGORY DATA

  • Summary 40 Protein ready to drink
  • Summary 41 Protein bars
  • Summary 42 Protein powder
  • Summary 43 Other Sports Nutrition Products
  • Table 82 Sales of Sports Nutrition: Value 2005-2010
  • Table 83 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 84 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 85 Sports Nutrition Company Shares 2006-2010
  • Table 86 Sports Nutrition Brand Shares 2007-2010
  • Table 87 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 88 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Brazil - Category Analysis

HEADLINES

TRENDS

  • Manufacturers are very positive about the potential of the Brazilian market for vitamins and dietary supplements as life expectancy reached 73.2-years-old and it grows each year. Additionally, disposable income of the population increased significantly over the review period, and thus, it contributed to consumers gaining access to these kinds of products. According to Euromonitor International estimates, households with a monthly disposable income over US$1,000 increased from 21.3% in 2005 to 46.7% in 2010.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Wyeth Indústria Farmacêutica Ltda remains the leading player in vitamins and dietary supplements with a value share of nearly 16% in 2010. The company continued to increase its share in 2010 despite problems with the distribution of Centrum in 2009 as the company decided to transfer the production of the product from Mexico to Canada, and thus, faced some problems when trying to update the registration at ANVISA.

PROSPECTS

  • In Brazil, it is very common that sales of a certain vitamin and dietary supplement will experience a boost after TV programmes, such as Globo Repórter, mention the benefits of a certain food, fruit or beverage and after a few months sales remain steady or decline. Therefore, it is expected that manufacturers will channel their investment into products that have the potential to increase over a long term period or target senior consumers that are prone to purchasing products such as calcium supplements, probiotic supplements, eye health supplements, fish oils and multivitamins.

CATEGORY DATA

  • Summary 44 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 91 Dietary Supplements by Positioning 2005-2010
  • Table 92 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 93 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 94 Vitamins Brand Shares by Value 2007-2010
  • Table 95 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Brazil - Category Analysis

HEADLINES

TRENDS

  • Due to the abusive use of sibutramine and other Rx medicines prescribed to reduce weight in Brazil, ANVISA (Health Surveillance Agency) tightened the purchase of sibutramine in Brazil. Prior to that, consumers could acquire sibutramine without medical prescription and the new rule established by ANVISA required that all prescriptions have to be retained in parapharmacies/drugstores. As a result of tightened surveillance over sibutramine sales, weight management manufacturers saw the opportunity to increase sales of meal replacement and weight loss supplements.

COMPETITIVE LANDSCAPE

  • Herbalife International is the outright leader with a value share of more than 51% in 2010. The success of the company is based on direct sales of its meal replacement product under the Shapeworks brand name. The company has a wide number of associates who are responsible for distributing Herbalife products across the national territory. Due to the strength of the distribution network, Herbalife maintained its market share in 2010.

PROSPECTS

  • Weight management is expected to maintain a great performance over the forecast period as access to Rx medicines to reduce weight will continue to be restricted and further measures will be adopted by ANVISA to hinder sales of illegal drugs in the Brazilian market. As a result, Euromonitor International estimates that weight management will increase at a CAGR of 5% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 98 Sales of Weight Management: Value 2005-2010
  • Table 99 Sales of Weight Management: % Value Growth 2005-2010
  • Table 100 Weight Management Company Shares 2006-2010
  • Table 101 Weight Management Brand Shares 2007-2010
  • Table 102 Forecast Sales of Weight Management: Value 2010-2015
  • Table 103 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • In Brazil, the greatest challenge is to increase sales per capita of wound treatment, which is about R$2. Manufacturers have invested in promotions and decorative sticking plasters to increase sales but sales per capita still remain low. The big issue is that lower-income brackets usually do not use sticking plasters when they get hurt and prefer to use basic methods to clean wounds.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Indústria e Comércio is the leading manufacturer, holding a 47% value share in 2010 due to the tradition and popularity of Band-Aid. The company continued to increase market share despite a lack of investment in advertising campaigns and merchandising action at the point-of-sale.

PROSPECTS

  • Wound care is expected to show moderate growth rates over the forecast period. Euromonitor International estimates that wound care will increase by less than 2% in constant value terms from 2010 to 2015.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2005-2010
  • Table 105 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 106 Wound Care Company Shares by Value 2006-2010
  • Table 107 Wound Care Brand Shares by Value 2007-2010
  • Table 108 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Fibre
            • Guarana
            • Isoflavones
            • Noni
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market Sizes
    • Company Shares
    • Brand Shares
    • Distribution
    • Analysis by Format
    • Analysis by Positioning
    • Analysis by Type
    • Herbal/Traditional vs Standard
    • Pricing

    Market size details:

    • Retail Volume
    • Retail Volume % growth
    • Retail Volume per capita
    • Retail Value retail selling price % growth
    • Retail Value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value retail selling price real (constant 2008) Prices % growth
    • Retail Value retail selling price real (constant 2008) Prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value retail selling price real (constant 2008) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price % growth
    • Retail Value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price real (constant 2008) Prices % growth
    • Retail Value manufacturer selling price real (constant 2008) Prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price real (constant 2008) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value retail selling price Nominal (Current) Prices % growth
    • Retail Value retail selling price Nominal (Current) Prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value retail selling price Nominal (Current) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price Nominal (Current) Prices % growth
    • Retail Value manufacturer selling price Nominal (Current) Prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail Value manufacturer selling price Nominal (Current) Prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    RELATED

    Future Demographic

    Country Report

    Consumer Lifestyle

    Country Report